Therapy Areas: Vaccines
GeoVax Labs completes enrolment of nine patients in Phase 1/2 trial of DNA/MVA vaccine
14 January 2013 - GeoVax Labs, an Atlanta-based vaccine developer, has completed the enrolment of nine patients in a Phase 1/2 trial evaluating the safety, immunogenicity and ability of its DNA/MVA va...
Bavarian Nordic to concentrate vaccine production in Denmark
14 January 2013 - 14 January 2013 - Danish biotech firm Bavarian Nordic A/S (CPH:BAVA) said Friday it would consolidate its vaccine manufacturing operations in Kvistgaard, Denmark, in a bid to enhance...
Grifols announces strong inventory of HyperRAB S/D
1 October 2012 - Grifols, a healthcare company that produces medicines derived from human plasma, announced on Friday that it has a strong inventory of HyperRAB(r) S/D to overcome United States supply...
Dynavax gives update on Heplisav pre-BLA meeting with FDA
3 February 2012 - US Dynavax Technologies Corp (NASDAQ:DVAX) said on Thursday it met with the US Food and Drug Administration (FDA) in a Pre-Biologics License Application (pre-BLA) meeting, and that t...
IDRI provides support to human hookworm vaccine trial
1 February 2012 - The Infectious Disease Research Institute (IDRI) said on Tuesday that it is providing technical support to the Sabin Vaccine Institute's (Sabin) Phase I clinical trial of a huma...
Inovio reports encouraging results in development of universal flu vaccine
31 January 2012 - Inovio Pharmaceuticals Inc (NYSEAMEX:INO), a US-based vaccine development company, said on Tuesday that its synthetic vaccines for influenza Type A H3N2 and Type B achieved protectiv...